Cargando…
Pregnancy exposure registries for drugs and vaccines in low-income and middle-income countries: scoping review protocol
INTRODUCTION: Data regarding the safety of drugs and vaccines in pregnant women are typically unavailable before licensure. Pregnancy exposure registries (PERs) are an important source of postmarketing safety information. PERs in low-income and middle-income countries (LMICs) are uncommon but can pr...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10174003/ https://www.ncbi.nlm.nih.gov/pubmed/37156596 http://dx.doi.org/10.1136/bmjopen-2022-070543 |
_version_ | 1785039944116338688 |
---|---|
author | AbuShweimeh, Rahmeh Knudson, Sophie Chaabane, Sonia Pal, Shanthi Narayan Skidmore, Becky Stergachis, Andy Bhat, Niranjan |
author_facet | AbuShweimeh, Rahmeh Knudson, Sophie Chaabane, Sonia Pal, Shanthi Narayan Skidmore, Becky Stergachis, Andy Bhat, Niranjan |
author_sort | AbuShweimeh, Rahmeh |
collection | PubMed |
description | INTRODUCTION: Data regarding the safety of drugs and vaccines in pregnant women are typically unavailable before licensure. Pregnancy exposure registries (PERs) are an important source of postmarketing safety information. PERs in low-income and middle-income countries (LMICs) are uncommon but can provide valuable safety data regarding their distinct contexts and will become more relevant as the introduction and use of new drugs and vaccines in pregnancy increase worldwide. Strategies to support PERs in LMICs must be based on a better understanding of their current status. We developed a scoping review protocol to assess the landscape of PERs that operate in LMICs and characterise their strengths and challenges. METHODS AND ANALYSIS: This scoping review protocol follows the Joanna Briggs Institute manual for scoping reviews. The search strategy will be reported using the Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews Checklist. We will search PubMed, Embase, CINAHL and WHO’s Global Index Medicus, as well as the reference lists of retrieved full-text records, for articles published between 2000 and 2022 that describe PERs or other resources that systematically record exposures to medical products during pregnancy and maternal and infant outcomes in LMICs. Title and abstracts will be screened by two authors and data extracted using a standardised form. We will undertake a grey literature search using Google Scholar and targeted websites. We will distribute an online survey to selected experts and conduct semistructured interviews with key informants. Identified PERs will be summarised in tables and analysed. ETHICS AND DISSEMINATION: Ethical approval is not required for this activity, as it was determined not to involve human subjects research. Findings will be submitted to an open access peer-reviewed journal and may be presented at conferences, with underlying data and other materials made publicly available. |
format | Online Article Text |
id | pubmed-10174003 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-101740032023-05-12 Pregnancy exposure registries for drugs and vaccines in low-income and middle-income countries: scoping review protocol AbuShweimeh, Rahmeh Knudson, Sophie Chaabane, Sonia Pal, Shanthi Narayan Skidmore, Becky Stergachis, Andy Bhat, Niranjan BMJ Open Obstetrics and Gynaecology INTRODUCTION: Data regarding the safety of drugs and vaccines in pregnant women are typically unavailable before licensure. Pregnancy exposure registries (PERs) are an important source of postmarketing safety information. PERs in low-income and middle-income countries (LMICs) are uncommon but can provide valuable safety data regarding their distinct contexts and will become more relevant as the introduction and use of new drugs and vaccines in pregnancy increase worldwide. Strategies to support PERs in LMICs must be based on a better understanding of their current status. We developed a scoping review protocol to assess the landscape of PERs that operate in LMICs and characterise their strengths and challenges. METHODS AND ANALYSIS: This scoping review protocol follows the Joanna Briggs Institute manual for scoping reviews. The search strategy will be reported using the Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews Checklist. We will search PubMed, Embase, CINAHL and WHO’s Global Index Medicus, as well as the reference lists of retrieved full-text records, for articles published between 2000 and 2022 that describe PERs or other resources that systematically record exposures to medical products during pregnancy and maternal and infant outcomes in LMICs. Title and abstracts will be screened by two authors and data extracted using a standardised form. We will undertake a grey literature search using Google Scholar and targeted websites. We will distribute an online survey to selected experts and conduct semistructured interviews with key informants. Identified PERs will be summarised in tables and analysed. ETHICS AND DISSEMINATION: Ethical approval is not required for this activity, as it was determined not to involve human subjects research. Findings will be submitted to an open access peer-reviewed journal and may be presented at conferences, with underlying data and other materials made publicly available. BMJ Publishing Group 2023-05-08 /pmc/articles/PMC10174003/ /pubmed/37156596 http://dx.doi.org/10.1136/bmjopen-2022-070543 Text en © Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY. Published by BMJ. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Obstetrics and Gynaecology AbuShweimeh, Rahmeh Knudson, Sophie Chaabane, Sonia Pal, Shanthi Narayan Skidmore, Becky Stergachis, Andy Bhat, Niranjan Pregnancy exposure registries for drugs and vaccines in low-income and middle-income countries: scoping review protocol |
title | Pregnancy exposure registries for drugs and vaccines in low-income and middle-income countries: scoping review protocol |
title_full | Pregnancy exposure registries for drugs and vaccines in low-income and middle-income countries: scoping review protocol |
title_fullStr | Pregnancy exposure registries for drugs and vaccines in low-income and middle-income countries: scoping review protocol |
title_full_unstemmed | Pregnancy exposure registries for drugs and vaccines in low-income and middle-income countries: scoping review protocol |
title_short | Pregnancy exposure registries for drugs and vaccines in low-income and middle-income countries: scoping review protocol |
title_sort | pregnancy exposure registries for drugs and vaccines in low-income and middle-income countries: scoping review protocol |
topic | Obstetrics and Gynaecology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10174003/ https://www.ncbi.nlm.nih.gov/pubmed/37156596 http://dx.doi.org/10.1136/bmjopen-2022-070543 |
work_keys_str_mv | AT abushweimehrahmeh pregnancyexposureregistriesfordrugsandvaccinesinlowincomeandmiddleincomecountriesscopingreviewprotocol AT knudsonsophie pregnancyexposureregistriesfordrugsandvaccinesinlowincomeandmiddleincomecountriesscopingreviewprotocol AT chaabanesonia pregnancyexposureregistriesfordrugsandvaccinesinlowincomeandmiddleincomecountriesscopingreviewprotocol AT palshanthinarayan pregnancyexposureregistriesfordrugsandvaccinesinlowincomeandmiddleincomecountriesscopingreviewprotocol AT skidmorebecky pregnancyexposureregistriesfordrugsandvaccinesinlowincomeandmiddleincomecountriesscopingreviewprotocol AT stergachisandy pregnancyexposureregistriesfordrugsandvaccinesinlowincomeandmiddleincomecountriesscopingreviewprotocol AT bhatniranjan pregnancyexposureregistriesfordrugsandvaccinesinlowincomeandmiddleincomecountriesscopingreviewprotocol |